A series of 2-imino-2-chromen-3-yl-1,3,5-triazine compounds ⁻, which are namely hybrids of 2,4-diamino-1,3,5-triazines and 2-imino-coumarins, was synthesized by reacting 2-(4,6-diamine-1,3,5-triazin-2-yl)acetonitriles ⁻ with 2-hydroxybenzaldehydes. After this, upon heating in aqueous DMF, 2-imino-2-chromen-3-yl-1,3,5-triazines and were converted into the corresponding 2-chromen-3-yl-1,3,5-triazines and , which are essentially hybrids of 2,4-diamino-1,3,5-triazines and coumarins. The in vitro anticancer activity of the newly prepared compounds was evaluated against five human cancer cell lines: DAN-G, A-427, LCLC-103H, SISO and RT-4. The greatest cytotoxic activity displayed 4-[7-(diethylamino)-2-imino-2-chromen-3-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazin-2-amine (11, IC in the range of 1.51⁻2.60 μM).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099606 | PMC |
http://dx.doi.org/10.3390/molecules23071616 | DOI Listing |
Molecules
July 2018
Department of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, Poland.
A series of 2-imino-2-chromen-3-yl-1,3,5-triazine compounds ⁻, which are namely hybrids of 2,4-diamino-1,3,5-triazines and 2-imino-coumarins, was synthesized by reacting 2-(4,6-diamine-1,3,5-triazin-2-yl)acetonitriles ⁻ with 2-hydroxybenzaldehydes. After this, upon heating in aqueous DMF, 2-imino-2-chromen-3-yl-1,3,5-triazines and were converted into the corresponding 2-chromen-3-yl-1,3,5-triazines and , which are essentially hybrids of 2,4-diamino-1,3,5-triazines and coumarins. The in vitro anticancer activity of the newly prepared compounds was evaluated against five human cancer cell lines: DAN-G, A-427, LCLC-103H, SISO and RT-4.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!